Sansanmycins were a group of nucleosidyl–peptide antibiotics, produced by Streptomyces sp SS (CGMCC no. 1764).1, 2, 3, 4 During our further studies on minor components of Sansanmycins, two new components, Sansanmycin F and G, were obtained. In this paper, we report the production, isolation, structure elucidation and biological activities of Sansanmycin F and G (Figure 1).
Streptomyces sp SS wase cultured as described previously.1 Antibiotic activity was determined by a paper-disk agar diffusion assay using Pseudomonas aeruginosa on Mueller–Hinton medium. The fermentation broth was filtered to remove mycelia; 50 l of filtrate thus obtained was applied on a column of Amberlite XAD-2 (Rohm and Haas Co., Philadelphia, PA, USA) (5 l) and, after washing with 25 l of water and 20 l of 10% aqueous acetone successively, the absorbed materials were eluted with 20 l of 30% aqueous acetone. The active fraction was concentrated in vacuo and lyophilized to obtain a crude powder (30.0 g). Thereafter, 5 g of the crude powder was dissolved in 100 ml 0.1% (w/v) (NH4)2CO3 aqueous solution, and then applied on a column of Amberlite XAD1180 (1.25 l). After washing with 15 l of 8% aqueous acetone, the column was sequentially eluted with 15% (10 l) and 30% (10 l) of aqueous acetone to yield 100 fractions, each of which was analyzed by HPLC-UV (XTerra MS C18 column (Waters, Dublin, Ireland), 150 × 4.6 mm, 5 μm; MeOH/0.1% (w/v) (NH4)2CO3, 3:7 (v/v); flow rate, 1 ml min−1; UV detection at 254 nm and oven temperature at 40 °C). Fractions 60–80, containing Sansanmycin F and G, were combined, concentrated in vacuo and lyophilized to obtain a mixture of Sansanmycin F and G (100 mg). Further separation was achieved by means of preparative RP-HPLC (Shim-pack PREP-ODS column (Shim-pack, Kyoto, Japan), 250 × 20 mm, 10 μm; eluted with a gradient of buffer A (0.1% (w/v) (NH4)2CO3-MeOH, 65:35 (v/v)) to buffer B ((0.1% (w/v) (NH4)2CO3-MeOH, 55:45 (v/v); flow rate, 5 ml min−1; UV detection at 254 nm and oven temperature at 40 °C) to yield Sansanmycin F (15 mg) and G (10 mg).
Sansanmycin F is a white amorphous powder; electrospray ionization (ESI)-MS m/z 904.6 [M+H]+, HR-ESI-MS m/z 904.36496 [M+H]+ (calcd for C43H54N9O11S, 904.36635). 1H and 13C NMR spectra of Sansanmycin F (Table 1) were similar to those of Sansanmycin,1 except that there were new signals in the NMR spectra of Sansanmycin F instead of m-tyrosine residue in Sansanmycin. A series of NMR (1H NMR, 13C NMR, 1H-1H COSY, heteronuclear multiple quantum coherence (HMQC) and heteronuclear multiple bond coherence (HMBC)) data indicated that it had the 1,1-dimethyl-6-hydroxy-1,2,3,4-tetradhydro-3-isoquinoline carboxylic acid (TIC) (Figure 2) as the blocked N terminus, similar to Napsamycin B,5 which had 1-methyl-6-hydroxy-1,2,3,4-tetradhydro-3-isoquinoline carboxylic acid, and Mureidomycin F,6 which had 6-hydroxy-1,2,3,4-tetradhydro-3-isoquinoline carboxylic acid as the blocked N terminus. The proton resonances at δ 6.75 and 7.18 were coupled (1H-1H COSY) and corresponded to positions of 7 and 8 of TIC, respectively. The signals at δ 117.6, 137.1 and 156.7 were all coupled (HMBC) to the proton of TIC-7 and were assigned as carbons of 5, 9 and 6 of TIC, respectively. The carbonyl that resonated at δ 176.8 and coupled to the proton of the N-methyl protons was assigned as TIC carbonyl. Also coupled to TIC carbonyl were the protons at δ 4.01 (TIC-3) and δ 2.67 (TIC-4). The signal at δ 136.1, which was coupled to the protons of TIC-4 and TIC-3, was assigned as the carbon of TIC-10. The signal at δ 56.5 showing a cross-peak with protons of TIC-3 and TIC-8 was assigned as the carbon of TIC-1. The methyl proton resonances at both δ 1.46 and 1.35 were coupled to the carbons of TIC-1 and TIC-9, and corresponded to the two methyls of TIC-1. From these results, the structure of Sansanmycin F was elucidated as shown in Figure 1.
The total structure of Sansanmycin F was further confirmed by analysis of ESI-MS/MS spectra. The ESI-MS/MS data of the protonated molecular ion, m/z 904 (Figure 3), indicated that sequence selective fragmentations observed for Sansanmycin F showed complete similarity to those of sansanmycin,1 except those originating from the N terminus. The fragment ion m/z 176 also confirmed that Sansanmycin F had TIC as the N terminus.
Sansanmycin G is a white amorphous powder; ESI-MS m/z 886.7 [M+H]+, HR-ESI-MS m/z 886.40338 [M+H]+ (calcd for C44H56N9O11, 886.40993). Close examination of the 1H and 13C NMR data of Sansanmycin G suggested that it is similar to Sansanmycin F with a leucine moiety in place of the methionine unit. HPLC analyses of the alkaline hydrolysate (6 N NaOH, 110 °C, 16 h) of Sansanmycin G confirmed the presence of leucine residue. A series of 2D NMR experiments (1H-1H COSY, HMQC and HMBC) were performed, which allowed assignment of all 1H and 13C signals associated with each amino-acid unit and pseudo nucleoside residue (Table 1). The total structure of Sansanmycin G (Figure 1) was also further confirmed by analysis of ESI-MS/MS spectra (Figure 3).
Sansanmycin F and G had weak antibacterial activity, as shown in Table 2. Sansanmycin F exhibited inhibitory activity against P. aeruginosa with an MIC value of 16 μg ml−1. Sansanmycin F and G were further evaluated for their inhibitory activity against Mycobacterium tuberculosis H37Rv, on the basis of alarm blue microplate assay,7 with MIC values more than 16 μg ml−1.
Xie, Y. Y., Chen, R. X., Si, S. Y., Sun, C. H. & Xu, H. Z. A new nucleosidyl-peptide antibiotic, Sansanmycin. J Antibiot 60, 158–161 (2007).
Xie, Y. Y., Xu, H. Z., Si, S. Y., Sun, C. H. & Chen, R. X. Sansanmycins B and C, new components of Sansanmycins. J Antibiot 61, 237–240 (2008).
Xie, Y. Y., Xu, H. Z., Yu, Y. & Chen, R. X. Isolation, purification and structure determination of uridylpeptide antibiotic Sansanmycin D with activity against Pseudomonas aeruginosa. Chinese J Antibiot 34, 12–14 (2009).
Xie, Y. Y., Xu, H. Z., Yu, Y. & Chen, R. X. Isolation, purification and structure determination of uridylpeptide antibiotic sansanmycin E. Chinese J Antibiot 34, 326–328 (2009).
Chatterjee, S., Nadkarni, S. R., Vijayakumar, E. K., Patel, M. V. & Ganguli, B. N. Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82, 11372. J Antibiot 47, 595–598 (1994).
Isono, F. et al. Mureidomycins E and F, minor components of mureidomycins. J Antibiot 46, 1203–1207 (1993).
Collins, L. A. & Franzblau, S. G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrobial Agents Chemother 41, 1004–1009 (1997).
This study was supported by the Key New Drug Creation and Manufacturing Program (Grant nos. 2009ZX09301-003-4-2 and2009ZX09103-137) funded by The Ministry of Science and Technology of the People's Republic of China, and by the National Natural Science Foundation of China (NSFC Grant no. 30801448).
About this article
Cite this article
Xie, Y., Xu, H., Sun, C. et al. Two novel nucleosidyl–peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS. J Antibiot 63, 143–146 (2010). https://doi.org/10.1038/ja.2010.6
- antibacterial activity
- Sansanmycin F
- Sansanmycin G
- structure elucidation
Rescrutiny of the sansanmycin biosynthetic gene cluster leads to the discovery of a novel sansanmycin analogue with more potency against Mycobacterium tuberculosis
The Journal of Antibiotics (2019)
GKK1032C, a new alkaloid compound from the endophytic fungus Penicillium sp. CPCC 400817 with activity against methicillin-resistant S. aureus
The Journal of Antibiotics (2019)
Antibacterial Cyclic Lipopeptide Enamidonins with an Enamide-Linked Acyl Chain from a Streptomyces Species
Journal of Natural Products (2018)
Structure-based manual screening and automatic networking for systematically exploring sansanmycin analogues using high performance liquid chromatography tandem mass spectroscopy
Journal of Pharmaceutical and Biomedical Analysis (2018)